AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Tromphia is a prescription medication designed for adults suffering from moderately to severely active ulcerative colitis, demonstrating the potential to help manage symptoms effectively. At the one-year mark of treatment, many patients using Tromphia achieved clinical remission, with some even reaching endoscopic remission, showcasing its promise in long-term symptom management. However, it is important for patients to be aware of potential side effects, which include serious allergic reactions and a heightened risk of infections. Before initiating treatment, healthcare providers should assess patients for infections, including tuberculosis, to ensure patient safety.